BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3107859)

  • 1. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
    Bennett A; Cameron JS
    Clin Nephrol; 1987 Apr; 27(4):182-8. PubMed ID: 3107859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ristocetin induced platelet aggregation in children with nephrotic syndrome].
    Taira K; Okajima C; Yamashita T; Kawahara S; Matsunaga T; Nakajima M; Kamitsuji H
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):659-66. PubMed ID: 2214316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoinhibition of ristocetin-induced platelet aggregation.
    Nachman RL; Jaffe EA; Weksler BB
    J Clin Invest; 1977 Jan; 59(1):143-8. PubMed ID: 299747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin on platelet aggregation and plasma factor VIII level in normal man.
    Bensoussan D; Levy-Toledano S; Passa P; Caen J; Canivet J
    Diabete Metab; 1977 Dec; 3(4):223-7. PubMed ID: 304425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.
    Jackson CA; Greaves M; Patterson AD; Brown CB; Preston FE
    Br J Haematol; 1982 Sep; 52(1):69-77. PubMed ID: 6810912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of arachidonic acid by platelets in nephrotic syndrome.
    Schieppati A; Dodesini P; Benigni A; Massazza M; Mecca G; Remuzzi G; Livio M; de Gaetano G; Rossi EC
    Kidney Int; 1984 Apr; 25(4):671-6. PubMed ID: 6434788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
    Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome.
    Machleidt C; Mettang T; Stärz E; Weber J; Risler T; Kuhlmann U
    Kidney Int; 1989 Dec; 36(6):1119-24. PubMed ID: 2532267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced affinity for arachidonic acid in platelet-rich plasma from rats with Adriamycin-induced nephrotic syndrome.
    Delaini F; Poggi A; Donati MB
    Thromb Haemost; 1982 Dec; 48(3):260-2. PubMed ID: 6819645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.